# An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma

> **NCT05120986** · — · WITHDRAWN · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Asthma

## Interventions

- **OTHER:** IND/GLY/MF

## Key facts

- **NCT ID:** NCT05120986
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-15
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Novartis Farma - Produtos Farmaceuticos S.A. no longer commercializes the product.
- **Last updated:** 2022-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05120986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05120986, "An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05120986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*